Measurement of the intestinal permeability in chronic kidney disease

doi:10.5527/wjn.v5.i4.378

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6253)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

454

WORD

310

HTML

2750

Figures (1-3)

116

Tables (1-2)

143

Sum=3773

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1122

Download

1358

Sum=2480

Jul 6, 2016 (publication date) through Apr 29, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Nephrol. Jul 6, 2016; 5(4): 378-388
Published online Jul 6, 2016. doi: 10.5527/wjn.v5.i4.378

Full Size Figure Download Figure

Figure 3 Intestinal permeability end-stage renal disease patients (epidermal growth factor receptor < 15) vs healthy controls. ESRD: End stage renal disease.

Citation: Terpstra ML, Singh R, Geerlings SE, Bemelman FJ. Measurement of the intestinal permeability in chronic kidney disease. World J Nephrol 2016; 5(4): 378-388
URL: https://www.wjgnet.com/2220-6124/full/v5/i4/378.htm
DOI: https://dx.doi.org/10.5527/wjn.v5.i4.378